CDXS — CODEXIS, INC.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Measured signals that fired on CDXS
| date | signal | measured base rate |
|---|---|---|
| 2026-07-16 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-06-08 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-04-29 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-11 | De Vre Raymond Director | Open-market sale | 2.6K | 2.37 | 6.2K |
| 2026-02-24 | Lutz Stefan Chief Scientific Officer | Open-market sale | 5.9K | 1.13 | 6.6K |
| 2026-02-06 | Erbez Georgia See Remarks | Open-market sale | 3.8K | 1.31 | 5.0K |
| 2026-02-06 | MOORE ALISON President and CEO | Open-market sale | 3.8K | 1.31 | 5.0K |
| 2026-02-06 | Lutz Stefan Chief Scientific Officer | Open-market sale | 2.5K | 1.31 | 3.3K |
| 2026-01-07 | Lutz Stefan CSO | Open-market sale | 4.7K | 1.70 | 8.0K |
| 2025-12-01 | Opaleye Management Inc. | Open-market sale | 245.0K | 1.67 | 409.1K |
| 2025-12-01 | Opaleye Management Inc. | Open-market sale | 245.0K | 1.67 | 409.1K |
| 2025-12-01 | Opaleye Management Inc. | Open-market sale | 8.5K | 1.67 | 14.3K |
| 2025-12-01 | Opaleye Management Inc. | Open-market sale | 8.5K | 1.67 | 14.3K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Aberdeen Group plc | 14.1M | 8.7M |
| BlackRock, Inc. | 11.5M | 7.0M |
| Opaleye Management Inc. | 11.1M | 6.8M |
| Nantahala Capital Management, LLC | 6.7M | 4.1M |
| MILLENNIUM MANAGEMENT LLC | 6.5M | 4.0M |
| Telemark Asset Management, LLC | 6.3M | 3.8M |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.0M | 3.7M |
| AMERIPRISE FINANCIAL INC | 5.5M | 3.4M |
| UBS Group AG | 3.6M | 2.2M |
| GEODE CAPITAL MANAGEMENT, LLC | 3.1M | 1.9M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-13 | — | on EDGAR ↗ |
| 10-Q | 2026-08-11 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-11 | 2026-08-11 | on EDGAR ↗ |
| SCHEDULE 13G | 2026-07-29 | — | on EDGAR ↗ |
| 8-K | 2026-07-27 | 2026-07-23 | on EDGAR ↗ |
| 424B5 | 2026-07-24 | — | on EDGAR ↗ |
| 424B5 | 2026-07-23 | — | on EDGAR ↗ |
| 8-K | 2026-07-23 | 2026-07-23 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Codexis (CDXS) Q2 2026 Earnings Call Transcript · 2026-08-18
- Codexis outlines $72M-$76M 2026 revenue as it plans ~$25M GMP facility build-out · 2026-08-12
- Codexis, Inc. (CDXS) filed form 8-K · 2026-08-11 · SEC EDGAR
Ask the AI about CDXS
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →